Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.42 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21242301 | 0.98 | TAAR1 (0.48) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL23934035 | 0.96 | TAAR1 (0.47) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL19628486 | 0.94 | TAAR1 (0.52) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL8524202 | 0.86 | TAAR1 (0.56) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL11990712 | 0.86 | TAAR1 (0.56) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL6693090 | 0.82 | CSNK1E (0.56) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL9418115 | 0.82 | SIGMAR1 (0.56) | SIGMAR1 | |
| SCHEMBL22793495 | 0.82 | PNMT (0.39) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL25212657 | 0.81 | CSNK1E (0.58) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 | |
| SCHEMBL9242565 | 0.81 | CSNK1E (0.58) | TAAR1MAOASLC6A2SIGMAR1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210348169-A1 | METHODS FOR TREATING AGING AND SKIN DISORDERS USING NUCLEIC ACIDS TARGETING TYR OR MMP1 | PHIO PHARMACEUTICALS CORP. (US) | 2021-11-11 | — | — | US | disclosed |
| EP-0997474-B1 | Antithrombotic agents | PFIZER (US) | 2003-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210348169-A1 | METHODS FOR TREATING AGING AND SKIN DISORDERS USING NUCLEIC ACIDS TARGETING TYR OR MMP1 | MMP1, MMP3, MMP11 | TAAR1 3333/4885MAOA 606/4885SLC6A2 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.